Antiepileptic drugs and their impact on balance

Antiepileptic drugs (AEDs) are being used with increasing frequency, not only to manage epilepsy, but also in the treatment of other conditions including neuropathic pain, migraine headaches and psychiatric conditions requiring mood stabilization. Although AEDs as a class are commonly prescribed in older patients and those with a predisposition to imbalance, the effect these drugs exert on gait and equilibrium has received very little study. Data from controlled efficacy and safety trials suggests that some AEDs are more apt to affect balance than others, even at therapeutic doses. In particular, phenytoin, primidone and phenobarbital produce more dizziness than some of the newer AEDs such as lamotrigine, levetiracetam and oxcarbazepine. For some of the other new AEDs, the data are simply not sufficient to estimate their effect on balance. This article reviews the current evidence that may guide the clinician in choosing a medication likely to have a low impact on gait and balance. Considering the risks a...

[1]  R. Fisher,et al.  Measuring the effects of antiepileptic medications on balance in older people , 2006, Epilepsy Research.

[2]  B. Uthman,et al.  New onset geriatric epilepsy , 2005, Neurology.

[3]  A. Sólyom,et al.  Dose‐dependent Safety and Efficacy of Zonisamide: A Randomized, Double‐blind, Placebo‐controlled Study in Patients with Refractory Partial Seizures , 2005, Epilepsia.

[4]  A. Marson,et al.  Zonisamide add-on for drug-resistant partial epilepsy. , 2005, The Cochrane database of systematic reviews.

[5]  W. Hwang,et al.  Acute Phenytoin Intoxication: Causes, Symptoms, Misdiagnoses, and Outcomes , 2004, The Kaohsiung journal of medical sciences.

[6]  M. Brodie Zonisamide clinical trials: European experience , 2004, Seizure.

[7]  B. Parsons,et al.  Gabapentin: a pooled analysis of adverse events from three clinical trials in patients with postherpetic neuralgia. , 2004, The American journal of geriatric pharmacotherapy.

[8]  W. Löscher,et al.  The neurobiology of antiepileptic drugs for the treatment of nonepileptic conditions , 2004, Nature Medicine.

[9]  J. Salas-Puig,et al.  Seguridad del levetiracetam como tratamiento adyuvante en la epilepsia: el estudio SKATE en España , 2004 .

[10]  P. J. Bowman,et al.  Antiepileptic drug use increases rates of bone loss in older women , 2004, Neurology.

[11]  J. Sackellares,et al.  Randomized, Controlled Clinical Trial of Zonisamide as Adjunctive Treatment for Refractory Partial Seizures , 2004, Epilepsia.

[12]  R. Ramsay,et al.  Special considerations in treating the elderly patient with epilepsy , 2004, Neurology.

[13]  R. Mattson,et al.  Fractures, epilepsy, and antiepileptic drugs , 2004, Epilepsy & Behavior.

[14]  F. Matsuo,et al.  Long-term tolerability of lamotrigine: data from a 6-year continuation study , 2004, Epilepsy & Behavior.

[15]  G. Baker,et al.  Systematic screening allows reduction of adverse antiepileptic drug effects , 2004, Neurology.

[16]  I. Leppik,et al.  Epilepsy in the Elderly , 2002, Seminars in neurology.

[17]  S. Schmidt,et al.  Signs and symptoms of carbamazepine overdose , 1995, Journal of Neurology.

[18]  M. Morrell,et al.  Use of levetiracetam in a population of patients aged 65 years and older: a subset analysis of the KEEPER trial , 2003, Epilepsy & Behavior.

[19]  J. Cramer,et al.  Tolerability of levetiracetam in elderly patients with CNS disorders , 2003, Epilepsy Research.

[20]  A. Beydoun,et al.  Sustained Efficacy and Long‐term Safety of Oxcarbazepine: One‐year Open‐label Extension of a Study in Refractory Partial Epilepsy , 2003, Epilepsia.

[21]  L. Eberly,et al.  Antiepileptic drug use in nursing home admissions , 2003, Annals of neurology.

[22]  A. Beydoun,et al.  Safety and tolerability of oxcarbazepine in elderly patients with epilepsy , 2003, Epilepsy & Behavior.

[23]  D. H. Kennedy,et al.  The use of gabapentin for the treatment of postherpetic neuralgia. , 2003, Clinical therapeutics.

[24]  R. Mattson,et al.  Topiramate, carbamazepine and valproate monotherapy: double‐blind comparison in newly diagnosed epilepsy , 2003, Acta neurologica Scandinavica.

[25]  S. Gorman,et al.  Characterization Of Gabapentin Overdose Using A Poison Center Case Series , 2003, Journal of toxicology. Clinical toxicology.

[26]  M. Curran,et al.  Gabapentin , 2003, CNS drugs.

[27]  T. Tomson,et al.  Risk of Extremity Fractures in Adult Outpatients with Epilepsy , 2002, Epilepsia.

[28]  A. Marson,et al.  Lamotrigine add-on for drug-resistant partial epilepsy. , 2016, The Cochrane database of systematic reviews.

[29]  M. Morrell,et al.  The Expert Consensus Guideline Series Treatment of Epilepsy , 2001, Epilepsy & Behavior.

[30]  S. Schachter,et al.  Oxcarbazepine (Trileptal) as monotherapy in patients with partial seizures , 2001, Neurology.

[31]  M. Kalis,et al.  Oxcarbazepine, an antiepileptic agent. , 2001, Clinical therapeutics.

[32]  H. Meinardi,et al.  Tiagabine: Efficacy and Safety in Adjunctive Treatment of Partial Seizures , 2001, Epilepsia.

[33]  P. Penovich,et al.  Rapid initiation of gabapentin , 2001, Neurology.

[34]  H. Shill,et al.  Valproic acid toxicity mimicking multiple system atrophy , 2000, Neurology.

[35]  C. Elger,et al.  Oxcarbazepine Placebo‐Controlled, Dose‐Ranging Trial in Refractory Partial Epilepsy , 2000, Epilepsia.

[36]  C. Gross,et al.  Factors associated with antiepileptic drug use among elderly nursing home residents. , 2000, The journals of gerontology. Series A, Biological sciences and medical sciences.

[37]  M. Brodie,et al.  Multicentre, double-blind, randomised comparison between lamotrigine and carbamazepine in elderly patients with newly diagnosed epilepsy , 1999, Epilepsy Research.

[38]  J. Hanlon,et al.  Association of race and other potential risk factors with nonvertebral fractures in community-dwelling elderly women. , 1999, American journal of epidemiology.

[39]  M. Park,et al.  Lamotrigine Monotherapy in Newly Diagnosed Untreated Epilepsy: A Double‐Blind Comparison with Phenytoin , 1999, Epilepsia.

[40]  M. Iivanainen,et al.  Phenytoin: effective but insidious therapy for epilepsy in people with intellectual disability. , 1998, Journal of intellectual disability research : JIDR.

[41]  D. Chadwick,et al.  A double-blind trial of gabapentin monotherapy for newly diagnosed partial seizures , 1998, Neurology.

[42]  J. Sackellares,et al.  An active-control trial of lamotrigine monotherapy for partial seizures , 1998, Neurology.

[43]  I. Leppik,et al.  Antiepileptic Drug Use in Nursing Home Residents: Effect of Age, Gender, and Comedication on Patterns of Use , 1998, Epilepsia.

[44]  S. Noachtar,et al.  Gabapentin and carbamazepine affect eye movements and posture control differently: A placebo-controlled investigation of acute CNS side effects in healthy volunteers , 1998, Epilepsy Research.

[45]  J. Bruni Outcome Evaluation of Gabapentin as Add-on Therapy for Partial Seizures , 1998, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

[46]  J. Bruni ECONOMIC EVALUATION OF EPILEPSY MANAGEMENT . 1996. Edited by Ch Pachlatko and RG Beran. Published by John Libbey & Company Limited. 112 pages. $C48.00 approx. , 1998, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

[47]  H. Diener,et al.  Side effects from increased doses of carbamazepine on neuropsychological and posturographic parameters of humans , 1997, European Neuropsychopharmacology.

[48]  S. Kochen,et al.  A double-blind controlled clinical trial of oxcarbazepine versus phenytoin in adults with previously untreated epilepsy 1 This study was carried out on behalf of the International Adult Oxcarbazepine/Phenytoin Trial Group (see Appendix A). 1 , 1997, Epilepsy Research.

[49]  P. Wolf,et al.  Cerebellar atrophy decreases the threshold of carbamazepine toxicity in patients with chronic focal epilepsy. , 1997, Archives of neurology.

[50]  B. Steinhoff,et al.  A double-blind controlled clinical trial: oxcarbazepine versus sodium valproate in adults with newly diagnosed epilepsy 1 This work was carried out on behalf of the International Oxcarbazepine/Valproate Trial Group (see Appendix A). 1 , 1997, Epilepsy Research.

[51]  A. Marson,et al.  The New Antiepileptic Drugs: A Systematic Review of Their Efficacy and Tolerability , 1997, BMJ.

[52]  E. Ben-Menachem,et al.  Double-blind, placebo-controlled study of topiramate in patients with refractory partial epilepsy , 1996, Epilepsy Research.

[53]  G. Pledger,et al.  Double‐Blind, Placebo‐Controlled Trial of Topiramate (600 mg Daily) for the Treatment of Refractory Partial Epilepsy , 1996, Epilepsia.

[54]  E. Ben-Menachem,et al.  Double‐Blind, Placebo‐Controlled Trial of Topiramate as Add‐on Therapy in Patients with Refractory Partial Seizures , 1996, Epilepsia.

[55]  G. Pledger,et al.  Topiramate placebo-controlled dose-ranging trial in refractory partial epilepsy using 600-, 800-, and 1,000-mg daily dosages , 1996, Neurology.

[56]  G Lantos,et al.  Cerebellar atrophy in patients with long-term phenytoin exposure and epilepsy. , 1994, Archives of neurology.

[57]  W T Blume,et al.  Ataxia in Institutionalized Patients with Epilepsy , 1994, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

[58]  I. Leppik,et al.  Antiepileptics in the elderly. Pharmacoepidemiology and pharmacokinetics. , 1994, Archives of family medicine.

[59]  R. Mattson,et al.  Lamotrigine Therapy for Partial Seizures: A Multicenter, Placebo‐Controlled, Double‐Blind, Cross‐Over Trial , 1994, Epilepsia.

[60]  F. Matsuo,et al.  Placebo‐controlled study of the efficacy and safety of lamotrigine in patients with partial seizures , 1993, Neurology.

[61]  R W Baloh,et al.  Disequilibrium of unknown cause in older people , 1993, Annals of neurology.

[62]  N. Raz,et al.  Age-related regional differences in cerebellar vermis observed in vivo. , 1992, Archives of neurology.

[63]  A. Ylinen,et al.  Double‐Blind Study of Gabapentin in the Treatment of Partial Seizures , 1991, Epilepsia.

[64]  G. Ordog,et al.  Phenytoin toxicity: a review of 94 cases. , 1989, Veterinary and human toxicology.

[65]  Y. Løyning,et al.  A double-blind study comparing oxcarbazepine and carbamazepine in patients with newly diagnosed, previously untreated epilepsy , 1989, Epilepsy Research.

[66]  S. Torp,et al.  Atrophy of the cerebellar vermis in ageing A morphometric and histologic study , 1986, Journal of the Neurological Sciences.

[67]  E. Beghi,et al.  Adverse Reactions to Antiepileptic Drugs: A Multicenter Survey of Clinical Practice , 1986 .

[68]  J. Cramer,et al.  Comparison of carbamazepine, phenobarbital, phenytoin, and primidone in partial and secondarily generalized tonic-clonic seizures. , 1985, The New England journal of medicine.

[69]  A. Patat,et al.  Effect on postural sway of various benzodiazepine tranquillizers. , 1985, British journal of clinical pharmacology.

[70]  F. Bermejo,et al.  Truncal ataxia in chronic anticonvulsant treatment Association with drug-induced folate deficiency , 1982, Journal of the Neurological Sciences.

[71]  F. Mcdowell,et al.  Neurological sequelae following Dilantin® overdose in a patient and in experimental animals , 1965, Neurology.